CURE vs MLPR
Direxion Daily Healthcare Bull 3X Shares compared with ETRACS Quarterly Pay 1.5X Leveraged Alerian MLP Index ETN on yield, payout growth, payment schedule, cost and risk.
CURE
Direxion Daily Healthcare Bull 3X Shares
TTM yield · Quarterly
MLPR
ETRACS Quarterly Pay 1.5X Leveraged Alerian MLP Index ETN
TTM yield · Quarterly
Quick take
- MLPR yields more today: 8.89% vs 1.10% (forward).
- CURE has grown its payout faster: 139.4%/yr vs 14.4%/yr over the last 5 years.
- Both pay every quarter.
- Over the last year CURE delivered the higher total return: +70.7% vs +41.4% (price change plus payouts).
- MLPR has the steadier distribution: consistency 91/100 vs 69/100.
Generated from the latest data on both pages. Not a recommendation.
Side by side
| Metric | CURE | MLPR |
|---|---|---|
| Share price | $136.48 | $79.51 |
| TTM yield | 0.92% | 8.39% |
| Forward yield | 1.10% | 8.89% |
| Annual payout per share | $1.50 | $7.068 |
| Payment frequency | Quarterly | Quarterly |
| Next ex-date | Sep 22, 2026 (est.) | Oct 13, 2026 (est.) |
| Expense ratio | 0.94% | — |
| 1-year payout growth | +14.6% | +7.7% |
| 5-year payout CAGR | +139.4% | +14.4% |
| Consecutive years of increases | 1 year | 4 years |
| Payout consistency (last 12) | 69/100 | 91/100 |
| 1-year total return | +70.7% | +41.4% |
| 1-year price return | +69.2% | +30.4% |
| Size (market cap / AUM) | 181.5M | 11.9M |
| Years paying | 14.7 | 6.2 |
| Sector / category | Trading--Leveraged Equity | Trading--Leveraged Equity |
✓ marks the more favourable figure where one exists (higher yield, growth, streak, consistency, return and size; lower cost, payout ratio and risk).
$10,000 invested today
| CURE | MLPR | |
|---|---|---|
| Shares | 73.3 | 125.8 |
| Income per year | $110 | $889 |
| Income per month (avg) | $9 | $74 |
At forward yields, before taxes. Model CURE · Model MLPR
Next payments
| Ex-date | Pay date | Per share | Status |
|---|---|---|---|
| CURE Sep 22, 2026 | Oct 6, 2026 | $0.375 | Est. |
| CURE Dec 22, 2026 | Jan 5, 2027 | $0.375 | Est. |
| CURE Mar 23, 2027 | Apr 6, 2027 | $0.375 | Est. |
| MLPR Oct 13, 2026 | Oct 27, 2026 | $1.767 | Est. |
| MLPR Jan 12, 2027 | Jan 26, 2027 | $1.767 | Est. |
| MLPR Apr 13, 2027 | Apr 27, 2027 | $1.767 | Est. |
Annual payouts per share
CUREMLPR
Regular payments only; the current year is year to date. Per-share amounts are not directly comparable when share prices differ, so read this chart for growth trends.
FAQ
Which has the higher dividend yield, CURE or MLPR?
MLPR currently has the higher trailing yield: CURE yields 0.92% and MLPR yields 8.39%. Yield changes daily with price, so check the live figures above.
How often do CURE and MLPR pay?
CURE pays every quarter and MLPR pays every quarter. CURE's next ex-date is Sep 22, 2026 and MLPR's is Oct 13, 2026.
Which has grown its dividend faster, CURE or MLPR?
CURE has grown its payout faster: 139.4%/yr vs 14.4%/yr over the last 5 years.
Is CURE or MLPR better for income?
It depends on what you are optimising for. CURE and MLPR differ in yield, growth, payment schedule and risk profile; the table above puts every metric side by side so you can weigh them for your own goals. This page is data, not advice.